Zerbaxa 1 g/0.5 g powder for concentrate for solution for infusion clinical trials

A Phase 1, open-label, non-comparative, multicenter clinical study to evaluate the safety, tolerability, and pharmacokinetics of ceftolozane/tazobactam (MK-7625A) in pediatric participants with nosocomial pneumonia

This study is looking at a new antibiotic treatment called Zerbaxa for children with a specific type of lung infection they get while in hospital. It aims to see how safe it is, how well children tolerate it, and how the body handles the medicine.